Devonian Health Group (GSD.V) Stock Price

Devonian Health Group Price

OTC·CLOSED
7.10
​
Market closed

Revenue has compounded at 33.0% per year over the past 7 years to 23.59 M CAD. Devonian Health Group's net margin stands at -25.5%, up from -226.9% several years earlier.

Devonian Health Group stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Devonian Health Group business model & stock analysis

Devonian Health Group, Inc. is a pharmaceutical company, which engages in the development of botanical drugs. The company is headquartered in Montmagny, Quebec and currently employs 6 full-time employees. The company went IPO on 2014-09-09. The firm's main activity is the development of botanical drugs from plant materials and algae for the treatment of inflammatory-autoimmune diseases, including ulcerative colitis and atopic dermatitis. The company is also involved in the development of value-added products for dermo-cosmetics and the distribution of pharmaceutical products through its subsidiary. The Company’s flagship product, Thykamine, the pharmaceutical product issued from its SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress. The Company’s flagship product, Thykamine, the pharmaceutical product issued from its SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress. The firm's cosmeceutical products include R-Spinasome and Purgenesis.

Frequently asked questions about Devonian Health Group

Converted at the current exchange rate, the Devonian Health Group share trades at 4.47 EUR (7.10 CAD).

The revenue cannot currently be calculated for Devonian Health Group.

The profit cannot currently be calculated for Devonian Health Group.

The P/E ratio cannot be calculated for Devonian Health Group at the moment.

The P/S cannot be calculated for Devonian Health Group currently.

The Eulerpool Quality Score for Devonian Health Group is 4/10.

The ISIN of Devonian Health Group is CA2518348834. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Devonian Health Group is GSD.V. The ticker symbol is used to trade Devonian Health Group shares on the stock exchange.

Fair ValueTerminal
5.89 CAD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
3.93 M CAD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CAD
Initial public offering
Sep 9, 2014
ISIN
CA2518348834
Cusip
251834107
Market capitalization
19.67 M CADMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
2.15
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-65.80 %
Last updated Oct 17, 2026, 1:43 AM

Devonian Health Group Peer Group

Devonian Health Group Ticker

OTC · DVHGF